NSW must lobby for a better federal hospital funding deal, an independent report prompted by a toxic dispute between medical workers and hospital administrators has recommended.
Australian researchers say they’ve found convergent evidence babies born with vitamin D deficiency are at a higher risk of developing ADHD, schizophrenia, and autism.
The cosmetics injectables industry is facing a seismic shift, with businesses facing a shake-up. The Australian put some of the industry’s most pressing questions to the regulator.
More than 500 patients undergoing cancer mutation testing have been affected by a blunder that’s led to at least one ‘adverse clinical health outcome’.
Australia’s largest medicinal cannabis company, Montu, convenes new working group to set principles for telehealth sector, appointing a well-known former health minister as its chair.
Australia wants to be the first country in the world to virtually eliminate cervical cancer. New data shows a policy change made a few years ago could help get us there.
Shrouded in controversy, tightly regulated but the science far from settled: inside the veiled world of Australia’s legal, cutting-edge, MDMA-led therapy.
Psychedelic medicine is being pushed further into the mainstream with the DVA to fund the therapies for ill veterans, as the TGA weighs up also allowing it for palliative care.
It started as a staff uprising, led by an unassuming intensive-care physician, that grew into a statewide probe and fears of a toxic culture gripping a health system.
A government website designed to provide expectant mothers with information about their birthing options has sparked anger and calls for investigation for only including a passing mention of obstetricians.
Original URL: https://www.theaustralian.com.au/author/penny-timms/page/2